UNSPSC 51241534: Hypromellose/naphazoline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP800. This VA Drug Class (OP800) classifies this compound as belonging to the group DECONGESTANTS, TOPICAL OPHTHALMIC.

UNSPSC 51241534 Hypromellose/naphazoline is a Commodity code for a combination ophthalmic medication used to treat eye irritation and redness, typically formulated as eye drops. State and local health departments, correctional facilities, school districts, and public clinics procure this pharmaceutical product as part of routine medical supply procurement. The code sits within the broader family of ophthalmic pharmaceuticals and reflects the standardized procurement of branded or generic formulations meeting USP or equivalent pharmaceutical standards. Issuing bodies treating this as a line item typically bundle it within larger medical supply RFQs or standing pharmaceutical contracts rather than as a discrete solicitation, which accounts for its low visibility in posted notices.

No recent state or local contract opportunities specifically tagged to UNSPSC 51241534 appear in the available procurement record. The code's narrow pharmaceutical scope and its typical inclusion as a schedule item within master pharmaceutical supply agreements means opportunities surface primarily through cooperative purchasing vehicles (such as state health department contracts, pharmaceutical GPOs, or regional medical supply consortia) rather than standalone RFPs or RFQs. Business development professionals should monitor state health procurement channels and standing pharmaceutical schedule awards from state purchasing offices and regional cooperative agreements to identify sustained demand for this formulation.